BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36798815)

  • 1. Editorial: Differential diagnoses of thyroid neoplasms: Molecular and histological features and the impact on follow-up.
    Sorrenti S; Lauro A; Pironi D; Calò PG; Ulisse S
    Front Oncol; 2023; 13():1125887. PubMed ID: 36798815
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
    Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
    Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary Thyroid Cancer Prognosis: An Evolving Field.
    Ulisse S; Baldini E; Lauro A; Pironi D; Tripodi D; Lori E; Ferent IC; Amabile MI; Catania A; Di Matteo FM; Forte F; Santoro A; Palumbo P; D'Andrea V; Sorrenti S
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
    Nilubol N; Zhang L; Kebebew E
    Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
    Deandreis D; Al Ghuzlan A; Leboulleux S; Lacroix L; Garsi JP; Talbot M; Lumbroso J; Baudin E; Caillou B; Bidart JM; Schlumberger M
    Endocr Relat Cancer; 2011 Feb; 18(1):159-69. PubMed ID: 21118976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Criteria for histopathologic diagnosis of thyroid cancer in a quick test of accuracy].
    Lange D; Sporny S; Sygut J; Kula D; Burkacka J; Jarzab M; Kulig A
    Wiad Lek; 2001; 54 Suppl 1():54-61. PubMed ID: 12182063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL; Wang J; Zhang FJ; Zhao N; Gao BL
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of incorporating ultrasound-guided core biopsy into the clinical workflow of indeterminate thyroid tumors.
    Chen CN; Hsieh MS; Lee YH; Yang TL
    J Formos Med Assoc; 2022 Oct; 121(10):2012-2019. PubMed ID: 35241347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid carcinoma--contemporary diagnostic principles and treatment].
    Szybiński P; Nowak W
    Przegl Lek; 2001; 58(7-8):809-13. PubMed ID: 11769392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular lesions of the thyroid.
    Mathur A; Olson MT; Zeiger MA
    Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging molecular markers for the prognosis of differentiated thyroid cancer patients.
    Baldini E; Sorrenti S; Tuccilli C; Prinzi N; Coccaro C; Catania A; Filippini A; Bononi M; De Antoni E; D'Armiento M; Ulisse S
    Int J Surg; 2014; 12 Suppl 1():S52-6. PubMed ID: 24862669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 13. [Papillary thyroid carcinoma from tall and columnar cells].
    Abrosimov AIu; Kozhushnaia SM
    Arkh Patol; 2011; 73(2):50-4. PubMed ID: 21695993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastases to the thyroid gland from renal cancer.
    Cesaretti M; Trotta M; Varaldo E; Ansaldo G; Leale I; Borgonovo G
    Tumori; 2013; 99(3):e107-10. PubMed ID: 24158077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series.
    Brignardello E; Corrias A; Isolato G; Palestini N; Cordero di Montezemolo L; Fagioli F; Boccuzzi G
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4840-3. PubMed ID: 18812481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advances in molecular pathogenesis of thyroid cancer].
    Aleha M; Meng QB; Yu JC; Kang WM; Cao ZJ; Tian SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):382-5. PubMed ID: 23987483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types.
    Cho J; Shin JH; Hahn SY; Oh YL
    Korean J Radiol; 2018; 19(5):1000-1005. PubMed ID: 30174490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid carcinoma with different histological patterns.
    Lin JD; Hsueh C; Huang BY
    Chang Gung Med J; 2011; 34(1):23-34. PubMed ID: 21392471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.
    VanderLaan PA; Marqusee E; Krane JF
    Cancer Cytopathol; 2012 Aug; 120(4):245-53. PubMed ID: 22434789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and diagnostic reproducibility of the thyroid cytology "indeterminate categories" SIAPEC/SIE 2014 in a consecutive series of 302 cases.
    Massa F; Caraci P; Sapino A; De Rosa G; Volante M; Papotti M
    J Endocrinol Invest; 2021 Apr; 44(4):803-809. PubMed ID: 32797379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.